Incremental long-term benefit of drug therapies for chronic obstructive pulmonary disease in quality of life but not mortality: a network meta-analysis

Incremental long-term benefit of drug therapies for chronic obstructive pulmonary disease in quality of life but not mortality: a network meta-analysis

Introduction The latest evidence revealed that dupilumab, an interleukin-4 (IL-4) and interleukin-13 (IL-13) blocker, significantly reduces the exacerbation risk in patients with chronic obstructive pulmonary disease (COPD). The efficacy of dupilumab compared with conventional inhaled drugs remains...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiong Pan, Jiongzhou Sun, Shiyuan Gao, Zian Liu, Yiwen Huang, Yixin Lian
Format: Article
Language:English
Published: Termedia Publishing House 2024-05-01
Series:Archives of Medical Science
Subjects:
drug therapy
chronic obstructive pulmonary disease
mortality
exacerbation
network meta-analysis
Online Access:https://www.archivesofmedicalscience.com/Incremental-long-term-benefit-of-drug-therapies-for-chronic-obstructive-pulmonary,183025,0,2.html
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.archivesofmedicalscience.com/Incremental-long-term-benefit-of-drug-therapies-for-chronic-obstructive-pulmonary,183025,0,2.html

Similar Items